A microarray study of MPP-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools

Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, Arkansas 72079, USA.
BMC Bioinformatics (Impact Factor: 2.67). 08/2005; 6 Suppl 2(Suppl 2):S8. DOI: 10.1186/1471-2105-6-S2-S8
Source: PubMed

ABSTRACT This paper describes a microarray study including data quality control, data analysis and the analysis of the mechanism of toxicity (MOT) induced by 1-methyl-4-phenylpyridinium (MPP+) in a rat adrenal pheochromocytoma cell line (PC12 cells) using bioinformatics tools. MPP+ depletes dopamine content and elicits cell death in PC12 cells. However, the mechanism of MPP+-induced neurotoxicity is still unclear.
In this study, Agilent rat oligo 22K microarrays were used to examine alterations in gene expression of PC12 cells after 500 muM MPP+ treatment. Relative gene expression of control and treated cells represented by spot intensities on the array chips was analyzed using bioinformatics tools. Raw data from each array were input into the NCTR ArrayTrack database, and normalized using a Lowess normalization method. Data quality was monitored in ArrayTrack. The means of the averaged log ratio of the paired samples were used to identify the fold changes of gene expression in PC12 cells after MPP+ treatment. Our data showed that 106 genes and ESTs (Expressed Sequence Tags) were changed 2-fold and above with MPP+ treatment; among these, 75 genes had gene symbols and 59 genes had known functions according to the Agilent gene Refguide and ArrayTrack-linked gene library. The mechanism of MPP+-induced toxicity in PC12 cells was analyzed based on their genes functions, biological process, pathways and previous published literatures.
Multiple pathways were suggested to be involved in the mechanism of MPP+-induced toxicity, including oxidative stress, DNA and protein damage, cell cycling arrest, and apoptosis.

Download full-text


Available from: Jonathan Daniel Wren, Jul 25, 2015
  • Source
    • "This type of analysis helps confirm that at least some of the responding genes have known connections to the system under study (eye development in this case), and also helps identify which genes are prime candidates for further study. Microarray experiments may implicate their involvement even though few or no publications exist describing how they interact with the other genes or the process under study (Mizumoto et al. 2005; Xu et al. 2005). The IRIDESCENT analysis showed that 21 of the 70 differentially expressed genes identified by microarray analysis have not been mentioned in the literature to date. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To study genes that are specifically expressed in the eyes, we employed microarray and in situ hybridization analyses to identify and characterize differentially expressed ocular genes in eyeless masterblind (mbl-/-) zebrafish (Danio rerio). Among 70 differentially expressed genes in the mbl-/- mutant identified by microarray analysis, 8 down-regulated genes were characterized, including 4 eye-specific genes, opsin 1 short-wave-sensitive 1 (opn1sw1), crystallinbetaa1b (cryba1b), crystallinbetaa2b (cryba2b), and crystallingamma M2d3 (crygm2d3); 2 eye and brain genes, ATPase, H+ transporting, lysosomal, V0 subunit c (atp6v0c) and basic leucine zipper and W2 domains 1a (bzw1a); and 2 constitutive genes, heat shock protein 8 (hspa8) and ribosomal protein L7a (rpl7a). In situ hybridization experiments confirmed down-regulation of these 8 ocular formation genes in mbl-/- zebrafish and showed their ocular and dynamic temporal expression patterns during zebrafish early development. Further, an automated literature analysis of the 70 differentially expressed genes identified a sub-network of genes with known associations, either with each other or with ocular structures or development, and shows how this study contributes to the current body of knowledge.
    Genome 04/2008; 51(3):222-35. DOI:10.1139/G07-098 · 1.56 Impact Factor
  • Source
    • "Therefore, both undifferentiated and NGF-differentiated PC12 cells are invaluable Parkinson's disease cellular models for studies on MPP + -induced neurotoxicity (Marongiu et al., 1988; Fonck and Baudry, 2001; Cappelletti et al., 1995) and neuroprotection induced by different compounds (Lee et al., 2003; Sheng et al., 2002; Qing et al., 2003). However, the mechanism of MPP + induced neurotoxicity is not clear and may involve multiple signaling messengers, such as reactive oxygen species (Hartley et al., 1994), phosphatidylinositol-3 kinase (Salinas et al., 2001), cAMP (Ribeiro et al., 2002) and others causing significant changes in gene expression (Xu et al., 2005). In our study, as expected, upon treatment of NGF-differentiated PC12 cells with MPP + , dose-and time-dependent LDH release and caspase-3 activation (data not shown) were observed, supporting the apoptotic contribution to MPP + -induced NGF-differentiated PC12 cell death. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nerve growth factor (NGF) differentiated pheochromocytoma PC12 cells exposed to 1-methyl-4-phenylpyridinium (MPP+) toxin were used as an in vitro pharmacological model of Parkinson's disease to examine the neuroprotective effects of 4-hydroxy-2,2,6,6-tetramethyl piperidine-n-oxyl (Tempol), a free radical scavenger and a superoxide dismutase-mimetic compound. MPP+-induced PC12 cell death was measured 72 h after exposure to 1.5 mM MPP+ by the release of lactate dehydrogenease, caspase-3 activation and stimulation of survival and stress mitogen-activated protein kinases. Exposure of PC12 cells to MPP+ activated ERK1 and ERK2 (forty-fold over control after 72 h), JNK1 and JNK2 (fourfold after 48 h) and p-38alpha (tenfold after 24 h). Pretreatment of PC12 cells with 500 microM Tempol, 1 h before induction of the MPP+ insult, reduced by 70% the release of LDH into the medium, inhibited caspase-3 activity by 30% and improved by 33% mitochondrial function, effects correlated with a 70% reduction in ERK1 and ERK2 phosphorylation activity. These findings support the neuroprotective effect of Tempol in the MPP+-induced PC12 cell death model and its use as a potential drug for treatment of Parkinson's disease.
    European Journal of Pharmacology 12/2006; 549(1-3):50-7. DOI:10.1016/j.ejphar.2006.08.022 · 2.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The MCBIOS 2004 conference brought together regional researchers and students in biology, computer science and bioinformatics on October 7th-9th 2004 to present their latest work. This editorial describes the conference itself and introduces the twelve peer-reviewed manuscripts accepted for publication in the Proceedings of the MCBIOS 2004 Conference. These manuscripts included new methods for analysis of high-throughput gene expression experiments, EST clustering, analysis of mass spectrometry data and genomic analysis
    BMC Bioinformatics 07/2005; 6(Suppl 2). DOI:10.1186/1471-2105-6-S2-S1 · 2.67 Impact Factor
Show more